Durante-Mangoni E - Search Results

1

Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases.

Zampino R, Vitrone M, Parrella A, Ragone E, Durante-Mangoni E. Zampino R, et al. J Chemother. 2018 Apr;30(2):129-130. doi: 10.1080/1120009X.2017.1376782. Epub 2017 Sep 19. J Chemother. 2018. PMID: 28925824

2

Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.

Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, Cesaro G, Ragone E, Durante Mangoni E, Ruggiero G. Adinolfi LE, et al. Br J Haematol. 2001 Jun;113(3):590-5. doi: 10.1046/j.1365-2141.2001.02824.x. Br J Haematol. 2001. PMID: 11380442 Free article.

3

Risk factors for "major" embolic events in hospitalized patients with infective endocarditis.

Durante Mangoni E, Adinolfi LE, Tripodi MF, Andreana A, Gambardella M, Ragone E, Precone DF, Utili R, Ruggiero G. Durante Mangoni E, et al. Am Heart J. 2003 Aug;146(2):311-6. doi: 10.1016/S0002-8703(02)94802-7. Am Heart J. 2003. PMID: 12891201

4

Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.

Zampino R, Marrone A, Durante Mangoni E, Santarpia L, Sica A, Tripodi MF, Utili R, Ruggiero G, Adinolfi LE. Zampino R, et al. J Med Virol. 2004 May;73(1):33-7. doi: 10.1002/jmv.20058. J Med Virol. 2004. PMID: 15042645

5

Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor.

Tripodi MF, Adinolfi LE, Ragone E, Durante Mangoni E, Fortunato R, Iarussi D, Ruggiero G, Utili R. Tripodi MF, et al. Clin Infect Dis. 2004 May 15;38(10):1394-400. doi: 10.1086/392503. Epub 2004 Apr 28. Clin Infect Dis. 2004. PMID: 15156477

6

Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B.

Marrone A, Zampino R, Portella G, Grimaldi M, Durante-Mangoni E, Santarpia L, Ruggiero G, Utili R. Marrone A, et al. J Viral Hepat. 2005 Mar;12(2):186-91. doi: 10.1111/j.1365-2893.2005.00619.x. J Viral Hepat. 2005. PMID: 15720534

7

Mild chronic hepatitis C with steatosis: which treatment?

Durante-Mangoni E, Zampino R, Ruggiero G, Adinolfi LE. Durante-Mangoni E, et al. Hepatology. 2005 May;41(5):1198. doi: 10.1002/hep.20670. Hepatology. 2005. PMID: 15830395 No abstract available.

8

Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B.

Zampino R, Durante Mangoni E, Marrone A, Utili R, Ruggiero G, Adinolfi LE. Zampino R, et al. Dig Dis Sci. 2005 Oct;50(10):1791-2. doi: 10.1007/s10620-005-2939-4. Dig Dis Sci. 2005. PMID: 16187175 No abstract available.

9

Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.

Adinolfi LE, Durante-Mangoni E, Zampino R, Ruggiero G. Adinolfi LE, et al. Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:52-5. doi: 10.1111/j.1365-2036.2005.02597.x. Aliment Pharmacol Ther. 2005. PMID: 16225474 Review.

10

Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.

Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE. Durante-Mangoni E, et al. Aliment Pharmacol Ther. 2006 Nov 1;24(9):1349-57. doi: 10.1111/j.1365-2036.2006.03114.x. Aliment Pharmacol Ther. 2006. PMID: 17059516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters